Vorapaxar-d5 Sulfate

• Catalog No.: V758202
• M. F.: C29H35FN2O8S
• M. W.: 590.6602032

SYNONYMS

• IUPAC name: sulfuric acid (^2H₅)ethyl N-[(1R,3aR,4aR,6R,8aR,9S,9aS)-9-[(E)-2-[5-(3-fluorophenyl)pyridin-2-yl]ethenyl]-1-methyl-3-oxo-dodecahydronaphtho[2,3-c]furan-6-yl]carbamate
• IUPAC Traditional name: sulfuric acid (^2H₅)ethyl N-[(1R,3aR,4aR,6R,8aR,9S,9aS)-9-[(E)-2-[5-(3-fluorophenyl)pyridin-2-yl]ethenyl]-1-methyl-3-oxo-decahydro-1H-naphtho[2,3-c]furan-6-yl]carbamate
• Synonyms: Sch 530348-d5; N-[(1R,3aR,4aR,6R,8aR,9S,9aS)-9-[(1E)-2-[5-(3-Fluorophenyl)-2-pyridinyl]ethenyl]dodecahydro-1-methyl-3-oxonaphtho[2,3-c]furan-6-yl]carbamic Acid Ethyl Ester-d5 Sulfate

DETAILS

Description (English)

Labelled Vorapaxar (V758200). SCH-530348 is a novel antiplatelet agent undergoing development by Schering-Plough Corp for the treatment and prevention of atherothrombosis. It is currently undergoing Phase-III clinical trials for acute coronary syndrome (u

REFERENCES

• Boyle, J., et al.: Curr. Vasc. Pharmacol., 3, 63 (2005)
• Jennings, L., et al.: Expert. Opin. Drug Metab. Toxicol., 1, 727 (2005)
• Chackalamannil, S., et al.: J. Med. Chem., 49, 5389 (2005)